Delivery Order SPE2DB20D1004-SPE2DB22FF6N7
- Not listed
- This federal contract award is for the delivery of Varenicline 0.5 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $4,473.71, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 26, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. AmerisourceBergen...
- This federal contract award is for the delivery of Varenicline 0.5 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,760.91, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of November 27, 2023, and is a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned in the information provided. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Varenicline 0.5 mg tablets (56 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $6,611.46 and an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This contract award is for the delivery of Varenicline 1 mg tablets (56 count bottles) to the Defense Logistics Agency (DLA). The $3,297.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,562,955,369 units of the medication Varenicline 0.5 mg tablet. The $2,327.19 firm-fixed-price contract has an ultimate completion date of December 1, 2023 and is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of 56 tablets of the prescription medication Varenicline 0.5 mg. The $5,978.02 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc. that provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Varenicline 1 mg tablets. The contract, valued at $1,014.75, is a firm fixed-price delivery order with a completion date of February 12, 2025. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award is for the delivery of Varenicline 0.5 mg tablets in 56-count packages to the Defense Logistics Agency (DLA). The ceiling value of the contract is $2,810.82, and it is a firm fixed-price delivery order contract type. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Varenicline 1 mg tablets. The contract has a ceiling value of $1,189.35 and runs through March 20, 2025. This is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award is for the delivery of Varenicline 1 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract has an award value of $2,880.05 and an ultimate completion date of January 21, 2025. The contract is a Firm Fixed Price Delivery Order, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside....
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF6N7Delivery Order
This federal contract award is for the delivery of Varenicline 0.5 mg tablets to the U.S. Defense Logistics Agency (DLA). The contract, awarded to prime contractor Amerisourcebergen Drug Corp, has a fixed price of $1,500.54 and a completion date of May 17, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering pharmaceutical and medical commodities to military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/16/22 |